Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.6040
-0.0180 (-2.89%)
Apr 24, 2026, 5:29 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 72.46 million as of April 24, 2026. Its market cap has decreased by -16.65% in one year.
Market Cap
72.46M
Enterprise Value
118.97M
Revenue
21.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since October 30, 2015, Nanologica AB's market cap has decreased from 73.54M to 72.46M, a decrease of -1.47%. That is a compound annual growth rate of -0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 72.46M | 5.13% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mendus AB | 300.97M |
| Xintela AB | 248.91M |
| Isofol Medical AB | 227.87M |
| Initiator Pharma | 221.79M |
| Xbrane Biopharma AB | 203.99M |
| Diamyd Medical AB | 194.97M |
| Active Biotech AB | 181.89M |
| AlzeCure Pharma AB | 164.90M |